Ralfinamide mesylate
SIGMA/SML0378 - ≥98% (HPLC)
Synonym: (2S)
CAS Number: 202825-45-4
Empirical Formula (Hill Notation): C17H19FN2O2 · CH3SO3H
Molecular Weight: 398.45
MDL Number: MFCD19690932
Linear Formula: C17H19FN2O2 · CH3SO3H
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C17H19FN2O2.CH4O3S/c1- |
| InChI key | CHQVNINIGBRKGZ-YDALLXLXSA |
| optical activity | [α]/D 10 to 15° (c=1 HOAc) |
| Quality Level | 100 ![]() |
| SMILES string | CS(O)(=O)=O.C[C@H](NCc1cc |
| solubility | H2O: >15 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Ralfinamide is a mixed sodium and N-type calcium channel blocker. |
| Biochem/physiol Actions: | Ralfinamide is a mixed sodium and N-type calcium channel blocker. Inhibiton is voltage-dependent, with higher potency against inactivated channels. Ralfinamide is two fold selective for tetrodotoxin (TTX)-resistant sodium channels compared with TTX-sensitive currents. |
| Features and Benefits: | This compound is featured on the Calcium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


